Code of Maine Rules
95 - INDEPENDENT AGENCIES
659 - THE MAINE VACCINE BOARD
Chapter 248 - LIST OF VACCINES TO BE PROVIDED BY THE UNIVERSAL CHILDHOOD IMMUNIZATION PROGRAM
Section 659-248-III - Authorized List of Uniform Childhood Vaccines

1. DTaP Vaccines (Diphtheria, Tetanus, acellular Pertussis)

2. Hepatitis A Vaccines

3. Hepatitis B Vaccines

4. Polio Vaccine

5. Hib Vaccines (Haemophilusinfluenzae type b)

6. HPV Vaccines (Human Papillomavirus)

7. Pneumococcal Vaccines

8. Meningococcal Conjugate Vaccines

9. Measles, Mumps and Rubella Vaccine

10. Rotavirus Vaccines

11. TDAP Vaccines (Tetanus Toxoid, Reduced Diphtheria Toxoid and acellular Pertussis - adolescent formulation)

12. Varicella Vaccine

13. Combination Vaccines

14. Influenza Vaccines

1. The Board shall annually review new vaccines and vaccines not on the authorized list and determine the feasibility of either adding or removing vaccines to or from the authorized uniform list in accordance with the criteria established in section II(B).

2. In the event the Boardwhether as a result of the above annual review or for any other reason determined appropriate by the Board,determines that revision of the authorized list of uniform vaccines is warranted, it may revise the uniform vaccine list by appropriate Board vote after conducting a public hearing in accordance with 5 M.R.S.A. §8052(2), provided any revision of the list of uniform vaccines be consistent with the criteria established in 22 M.R.S.A. §1066(3)(E) and Section 2(B) of these Rules.

3. Any revision of the uniform childhood vaccine list is contingent upon the availability of adequate funding through the assessment mechanism established by 22 M.R.S.A. §1066(5).

4. The Authorized List of Uniform Childhood Vaccines shall be published on the Maine Vaccine Board Website at: http://www.mevaccine.org/mevaccine.nsf/pages/for-providers.html

5. In the event that the ACIP modifies existing product recommendations or adds a new vaccine product to the Vaccines for Children program, the Board shall meet within 90 days of the ACIP decision and determine if modifications to the authorized list of uniform vaccines is warranted.